千金药业：2025年半年度归属于上市公司股东的净利润同比增长8.50%

Group 1 - The company reported a revenue of 1,817,998,691.42 yuan for the first half of 2025, representing a year-on-year decrease of 5.52% [1] - The net profit attributable to shareholders of the listed company was 127,725,142.44 yuan, showing a year-on-year increase of 8.50% [1]